“ NWBO strategically amended its MAA in July 2025 to include initial Flaskworks validation data. This allows the MHRA to approve the manufacturing process alongside the drug, ensuring the system is ready for immediate commercial launch rather than requiring a multi-month post-approval variation.”
I think you and your AI are completely wrong . I don’t recall any documentation to substantiate it . On the contrary , I believe company has said that they will be using artisan method initially upon approval.
And the AI’s conclusions are based on completely baseless assumption . Why don’t you ask your AI chat a follow up question “ MAA was not amended to include Flasworks. Can you update your answer taking into account the correction of this fact about MAA”
Or even better , use research mode if you have pro version and specify to include all citations from where the facts in the answer are derived/inferred/extrapolated etc